Supporting the Y220C-p53 specific engagement and mechanism of action, treatment with rezatapopt resulted in a rapid decrease in TP53 Y220C ctDNA, which correlated with radiographic tumor shrinkage (Fig. 6B and C). This evidence concerns the gene TP53 and neoplasm.